REBECCA LONG: Open Payments
NPI 1912619958 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 18 payments from 7 companies in 2025. Trend: 2023 $182 · 2024 $165 · 2025 $514
Food & beverage: $409Education: $104
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $170 |
| Otsuka America Pharmaceutical, Inc. | 1 | $115 |
| ABBVIE INC. | 4 | $112 |
| Janssen Pharmaceuticals, Inc | 3 | $46 |
| Lundbeck LLC | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Alkermes, Inc. | 1 | $18 |
Products named: ABILIFY MAINTENA, VRAYLAR, UZEDY, ABILIFY ASIMTUFII, INVEGA SUSTENNA, COBENFY, ARISTADA, SPRAVATO.
Industry payments across TX — which companies pay providers there.
